Current Laboratory Projects

Pipetting equipment
  • Generation of novel CD33-targeting antibodies and antibody-based therapeutics
  • Understanding the full diversity of CD33 epitopes for antibody-based targeting of AML
  • Developing innovative strategies to overcome the limitations of bispecific antibodies for improved AML immunotherapy
  • CRISPR/Cas9 genome editing-based genomic approach to improve safety of AML therapies
  • Overcoming checkpoint inhibition as an approach to combinatorial therapy for acute leukemias
  • Developing rational strategies to improve AML therapy with gemtuzumab ozogamicin¬†